DANAHER CORP /DE/
DHRNYSEComprehensive AI Analysis
Strategic AI Analysis for DHR
Checking whether the approved providers contain enough current financial data for a reliable report.
Latest results at a glance
Insights from the latest company results and reports
Quarterly Earnings Exceed Consensus
Reported EPS of $1.94 per share exceeded the same-quarter consensus estimate of $1.84 per share for the period ending 2026-06-30.
Revenue Growth Accelerates
Revenue for the quarter ended 2026-06-26 was $6.27bn, representing a 5.54% increase from $5.94bn in the same quarter of the prior year.
Diagnostics Segment Expands
Diagnostics revenue reached $1.13bn, accounting for 18.1% of consolidated revenue and growing 6.4% year over year.
Gross Margin Narrowing
Gross margin for the quarter ended 2026-06-26 was 57.64%, narrower than the 59.35% recorded in the same quarter of the previous year.
Company research evidence
Checked financial measurements with the values, reporting periods and measurement basis shown together. This evidence is available independently of the AI report.
Loading evidence…
Deep Dive Research
Source-linked company research for DHR
Revenue segmentation
Loading segment disclosures…